Diadema Partners’s Replimune Group REPL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.04M Buy
+305,000
New +$3.86M 0.52% 46
2026
Q2
– Sell
-100,660
Closed -$616K – 190
2026
Q1
$770K Sell
100,660
-130,337
-56% -$996K 0.13% 93
2025
Q4
$2.25M Buy
+230,997
New +$1.96M 0.39% 59
2025
Q3
– Sell
-32,483
Closed -$208K – 158
2025
Q2
$302K Sell
32,483
-42,047
-56% -$367K 0.09% 85
2025
Q1
$727K Sell
74,530
-39,470
-35% -$488K 0.19% 71
2024
Q4
$1.38M Hold
114,000
– – 0.59% 44

Other funds holding REPL

Diadema Partners's REPL Position: Q3 2026 in Review

Diadema Partners opened a new position in Replimune Group (REPL) in Q3 2026: 305,000 shares worth $4.04M. The stake represents 0.52% of the portfolio and ranks #46 among its holdings. This is a return to the name: Diadema Partners previously reported a position in REPL as recently as Q1 2026.

Diadema Partners first reported a position in REPL in Q4 2024 and has held it in 6 quarters since. 210 funds tracked by Wall St. Rank hold REPL as of Q3 2026.

  • Diadema Partners held 305,000 shares of Replimune Group worth $4.04M as of Q3 2026.
  • Replimune Group was a new Diadema Partners position in Q3 2026.
  • Replimune Group made up 0.52% of Diadema Partners's portfolio in Q3 2026, its #46 holding.
  • Diadema Partners first reported a position in Replimune Group in Q4 2024 and has held it in 6 quarters since.
  • 210 funds tracked by Wall St. Rank held Replimune Group as of Q3 2026.

Based on Diadema Partners's 13F filing for Q3 2026, filed 16 Nov 2026.